In Vitro Diagnostic (IVD) Reagents (Antibodies, Oligonucleotide, Nucleic Acid Probe) Market - Global Forecast to 2027 -

DUBLIN--()--The "In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Oligonucleotide, Nucleic Acid Probe), Technology (Immunoassay, Hematology, Microbiology), Use (Research, Analyte Specific Reagent), End User (IVD Manufacturer, Clinical Laboratory) - Global Forecast to 2027" report has been added to's offering.

The IVD reagents market is expected to grow at a CAGR of 7% from 2020 to 2027 to reach $77.6 billion by 2027

The growth in the IVD reagents market is mainly attributed to the factors such as increasing global prevalence of acute and chronic infectious diseases coupled with rising geriatric population, increasing adoption of flow cytometry techniques in research and academia, increase in funding for research activities, and rising proteomics and genomics research studies. Moreover, the growing demand for protein therapeutics and personalized medicines and emerging economies offer significant growth opportunities for the players operating in this market.

Moreover, the recent outbreak of COVID-19 is also expected to support the growth of the IVD reagents market for this segment. However, the clinical laboratories segment is expected to register the highest growth during the forecast period, due to the rising number of accredited clinical laboratories; growing collaborations, partnerships, and other strategies undertaken by the key players; and outbreak of COVID-19.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Insights

4.1. Overview

4.2. Drivers

4.2.1. Increasing Prevalence of Acute and Chronic Infectious Diseases

4.2.2. Increasing Funding for Research Activities

4.2.3. Increasing Adoption of Flow Cytometry Techniques

4.2.4. Rising Proteomics and Genomics Research Studies

4.3. Restraints

4.3.1. Stringent Regulations Antigen-Specific Reagents

4.4. Opportunities

4.4.1. Growing Demand for Protein Therapeutics and Personalized Medicines

4.4.2. Emerging Economies

4.5. Challenges

4.5.1. High Cost & Unfavorable Reimbursement Scenario

5. Global In-Vitro Diagnostic Reagents Market, By Technology

5.1. Introduction

5.2. Immunoassay/Immunochemistry

5.2.1. Enzyme-Linked Immunosorbent Assays (Elisa)

5.2.2. Western Blotting

5.2.3. Immunofluorescence

5.2.4. Immunohistochemistry

5.2.5. Functional Assays

5.2.6. Immunoprecipitation

5.2.7. Other Technologies

5.3. Biochemistry/Clinical Chemistry

5.4. Molecular Diagnostics

5.5. Microbiology

5.6. Hematology

5.7. Coagulation/Hemostasis

5.8. Urinalysis

5.9. Other Technologies

6. Global In-Vitro Diagnostic Reagents Market, By Type

6.1. Introduction

6.2. Antibodies

6.2.1. Antibodies Market, By Type Monoclonal Polyclonal

6.2.2. Antibodies Market, By Target CD TCR EGFR Other Targets

6.3. Purified Proteins or Peptides

6.4. Oligonucleotides

6.5. Nucleic Acid Probes

6.6. Other Reagents

7. Global In-Vitro Diagnostic Reagents Market, By Use

7.1. Introduction

7.2. Clinical Use

7.3. Research Use Only (RUO)

7.4. Analyte-Specific Reagents (ASRs)

8. Global In-Vitro Diagnostic Reagents Market, By End User

8.1. Introduction

8.2. Reference Laboratories

8.3. IVD Manufacturers

8.4. Academic and Research Institutes

8.5. Hospital Laboratories

9. Global In-Vitro Diagnostic Reagents Market, By Geography

10. Competitive Landscape

10.1. Introduction

10.2. Competitive Benchmarking

10.3. Market Share Analysis (2019)

10.3.1. Becton, Dickinson and Company (U.S.)

10.3.2. Thermo Fisher Scientific, Inc. (U.S.)

10.3.3. Merck KGAA (Germany)

11. Company Profiles

  • Abcam plc (U.K.)
  • Agilent Technologies Inc. (U.S.)
  • Beckman Coulter Inc. (U.S.)
  • Becton
  • Bio-Rad Laboratories Inc. (U.S.)
  • Bio-Synthesis Inc. (U.S.)
  • Bio-Techne Corporation (U.S.)
  • BioLegend Inc. (U.S.)
  • Bioline (U.K.)
  • DIACLONE SAS (France)
  • Dickinson and Company (U.S.)
  • Hologic Inc. (U.S.)
  • InBios International Inc. (U.S.)
  • LGC Biosearch Technologies (U.K.)
  • LakePharma Inc. (U.S.)
  • Merck KGaA (Germany)
  • RayBiotech Inc. (U.S.)
  • SDIX LLC (U.S.)
  • Sino Biological Inc. (China).
  • The Binding Site Group Ltd.(U.K.)
  • Thermo Fisher Scientific (U.S.)

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900